Reuters logo
BRIEF-Roche says FDA grants breakthrough therapy designation for ACE910 medicine
September 4, 2015 / 5:11 AM / 2 years ago

BRIEF-Roche says FDA grants breakthrough therapy designation for ACE910 medicine

Sept 4 (Reuters) - Roche Holding AG

* Says U.S. FDA grants breakthrough therapy designation for Roche's investigational medicine ACE910 for people with haemophilia A with factor VIII inhibitors Source text for Eikon: [here ] Further company coverage: (Reporting By Zurich Slot)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below